🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hongxi Wu

Guangxi University

ORCID: 0000-0003-3125-0320

Also affiliated with First Affiliated Hospital of Jiangxi Medical College, Jiangxi Maternal and Child Health Hospital, Guangxi Zhuang Autonomous Region Health and Family Planning

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Discovery of a photoactivatable dimerized STING agonist based on the benzo[ b ]selenophene scaffold”.

Discovery of a photoactivatable dimerized STING agonist based on the benzo[ b ]selenophene scaffold

Chemical Science(2023)10.1039/d2sc06860e
N/A
0.520DataRank · unranked
31 citations

Bin Yu, Xin Guan, Bin Song, Huikai Pan, Renbing Wang +9 more

2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop

Pharmacological Research(2021)10.1016/j.phrs.2021.105685
N/A
0.425DataRank · unranked
16 citations

Jiaping Ni, Ying Li, Ming‐Ying Lu, Yuchen Yao, Haixin Guo +10 more

Next-generation drug conjugates for breast cancer: Clinical prospects and mechanism-based strategies to overcome resistance

Drug Discovery Today(2026)10.1016/j.drudis.2026.104599
N/A
0.208DataRank · unranked
3 citations

Wenjing Liu, Wenjia Lu, Zhiyu Li, Hongxi Wu, Monong Zhao

Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti–programmed cell death protein‐1 therapy

Hepatology(2022)10.1002/hep.32316
N/A
0DataRank · unranked
35 citations

Li Yan, Guangjiang Shi, Shijia Du, Xiaobin Wang, Wanli Ye +10 more